Introduction
The Federal Motor Carrier Safety Administration (formerly the Office of Motor Carriers, Federal Highway Administration) sponsored a study to gather and analyze data on commercial motor vehicle driver rest and recovery cycles, effects of partial sleep deprivation, and prediction of subsequent performance. The work was carried out in cooperation with the Federal Railroad Administration, and Federal Aviation Administration, by the Walter Reed Army Institute of Research at the General Clinical Research Center/Johns Hopkins Bayview Medical Center. The study began in July 1994 and was completed in May 2000.
Parts 1 and 2 of this tech brief summarize the study final report, Effects of Sleep Schedules on Commercial Motor Vehicle Driver Performance (Report DOT-MC-00-133). The report will be available from the National Technical Information Service.
Part 1 of this tech brief describes the study background, purpose, and the methodology and results from the field portion of the study. Part 2 describes the methodology and results from the laboratory portion of the study as well as the overall results, applications, and need for additional research.
Laboratory Study: The Sleep Dose/Response Study
The cause-effect relationship between sleepiness and impaired performance is well established, but the relationship has not been quantified parametrically. This is a necessary step toward determining, for example, how much sleep is necessary to perform subsequent daytime tasks with nominal efficiency and safety. Therefore, the primary objectives of the study were to (1) determine the effects of four sleep/wake schedules on alertness and performance, and (2) develop an algorithmic model to predict performance on the basis of prior sleep parameters.
Subjects
Sixty-six subjects participated: 16 females, (ages 24-55, mean and median age = 43); and 50 males (ages 24-62, mean = 37, median = 35). All subjects held a valid commercial driver's license but they differed in terms of years of experience and the types of trucks or buses driven.
Design
The subjects spent 14.5 days in the laboratory: 3 days of training/baseline performance with 8 hours time in bed (TIB) each night; followed by 7 consecutive days of performance testing during which subjects were allowed either 3, 5, 7, or 9 hours TIB each night. This was followed by a 4-day recovery period during which performance testing was continued and subjects again obtained 8 hours TIB each night. Wake-up time was held constant at 0700 hours across all conditions to minimize disruption of circadian rhythms. All performance tests and physiological measures were conducted at the same times of day across all phases of the study.
T e c h B r i e f 
Data Analysis
Data were generally analyzed using a 3-way mixed Analysis of Variance (ANOVA) for the TIB group (3, 5, 7, or 9 hours/night), day (11 days; Baseline 1-Recovery 3), and time of day, with repeated measures on the latter two factors. The number of levels for the time-of-day factor depended upon the daily sampling rate for a given task (for example, 4 levels for STISIM, which was administered at 0730, 1030, 1330, 1930 hours) . Main effects for sleep group, day, and time of day, as well as their interactions, were analyzed. The interaction of TIB Group X Day, if significant, was further analyzed using simple main effects ANOVAs. Greenhouse-Geisser corrections were applied to all repeated-measures tests. Post-hoc comparisons among means were conducted using the Tukey HSD test. Results were deemed significant at p < .05.
Results and Discussion
In the laboratory study, the 3, 5, 7, and 9-hour TIB groups averaged 2.87, 4.66, 6.28, and 7.93 hours of sleep, respectively, across the 7 days. (See Figure 1) Group-related (i.e., sleep dose-dependent) differences in subsequent daytime performance were evident (and quantifiable) for several measures.
Even a relatively small reduction in average nighttime sleep duration (i.e., to 6.28 hours of sleep-the average amount of sleep obtained by the 7-hr group) resulted in measurably decremented performancee.g., on the PVT. This decrement was maintained across the entire 7 consecutive days of sleep restriction. (See Figures 2 and 3. ) This suggests that there was no compensatory or adaptive response to even this mild degree of sleep loss.
Following more severe sleep restriction-e.g., the 3-hr group-recovery of performance was not complete after 3 consecutive nights of recovery sleep, with 8 hours spent in bed on each night. Thus, full recovery from substantial sleep debt may require extended recovery sleep. It also suggests that daytime alertness and performance capacity is a function not only of an individual's circadian rhythm, time since the last sleep period, and duration of the last sleep period, but is also a function of his/her sleep history, extending back for at least several days. The temporal relationship between EEG-defined lapses in alertness and accidents on a simulated driving task was low. This indicates sleepiness-induced performance decrements most often occur without visually-observed electrophysiological evidence of impaired alertness.
Of the various performance measures used, the Psychomotor Vigilance Task (PVT) was deemed optimal. This was because:
